| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:10:15 UTC |
|---|
| Update date | 2020-09-17 15:42:22 UTC |
|---|
| Primary ID | FDB012586 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Citric acid |
|---|
| Description | Citric acid (citrate) is a weak tricarboxylic acid that is formed in the tricarboxylic acid cycle. In humans citric acid is produced endogenously or it may be introduced with diet, with citrus fruits being a key source. Citrate is produced by all aerobic organisms, from microbes to humans. Citrate is formed in the TCA cycle via the enzyme known as citrate synthase, which catalyzes the condensation of oxaloacetate with acetyl CoA to form citrate. Citrate then acts as the substrate for aconitase and is converted into aconitic acid. Some bacteria (notably E. coli) can produce and consume citrate internally as part of their TCA cycle, but are unable to use it as food because they lack the enzymes required to import it into the cell. Citrate has a number of biological roles in humans. In particular, it can be transported out of the mitochondria and into the cytoplasm, then broken down into acetyl-CoA for fatty acid synthesis. Citrate can also acts as a signalling molecule. High concentrations of cytosolic citrate can inhibit phosphofructokinase, the catalyst of a rate-limiting step of glycolysis. Inhibition of glycolysis has been shown to suppress tumor growth in a number of animal models ( PMID: 28674429). Citrate is also a vital component of bone, helping to regulate the size of apatite crystals. Urinary citrate levels can be used to identify a number of disorders. Indeed urinary citrate excretion is a common tool in the differential diagnosis of kidney stones, renal tubular acidosis and it plays also a role in characterizing bone diseases such as osteoporosis (PMID 12957820). The secretory epithelial cells of the prostate gland of humans and other animals possess a unique citrate-related metabolic pathway regulated by testosterone and prolactin. This specialized hormone-regulated metabolic activity is responsible for the major prostate function of the production and secretion of extraordinarily high levels of citrate. The key regulatory enzymes directly associated with citrate production in the prostate cells are mitochondrial aspartate aminotransferase, pyruvate dehydrogenase, and mitochondrial aconitase. Testosterone and prolactin are involved in the regulation of the corresponding genes associated with these enzymes (PMID 12198595). In addition to its biological roles and endogenous production, citrate is obtained from many other sources and used in many applications. Citric acid is found in citrus fruits, most concentrated in lemons and limes, where it can comprise as much as 8% of the dry weight of the fruit. The concentrations of citric acid in citrus fruits range from 5 mM for oranges and grapefruits to 300 mM in lemons and limes. However, these values vary within species depending upon the cultivar and the circumstances in which the fruit was grown. Citric acid is a natural preservative and is also used to add an acidic (sour) taste to foods and soft drinks. Citric acid is used as an excipient in pharmaceutical preparations due to its antioxidant properties. It can be used to treat water, which makes it useful in improving the effectiveness of soaps and laundry detergents. Citric acid is also used as an acidulant in creams, gels, and liquids. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. Intolerance to citric acid in the diet is known to exist. Altered levels of citric acid have been found to be associated with maple syrup urine disease, primary hypomagnesemia, propionic acidemia, and tyrosinemia I, which are inborn errors of metabolism. |
|---|
| CAS Number | 77-92-9 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 2-Hydroxy-1,2,3-propanetricarboxylic acid | ChEBI | | 2-Hydroxytricarballylic acid | ChEBI | | 3-Carboxy-3-hydroxypentane-1,5-dioic acid | ChEBI | | Citronensaeure | ChEBI | | e330 | ChEBI | | H3Cit | ChEBI | | Anhydrous citric acid | Kegg | | Citric acid anhydrous | Kegg | | 2-Hydroxy-1,2,3-propanetricarboxylate | Generator | | 2-Hydroxytricarballylate | Generator | | 3-Carboxy-3-hydroxypentane-1,5-dioate | Generator | | Anhydrous citrate | Generator | | Citrate anhydrous | Generator | | Citrate | Generator | | Aciletten | HMDB | | beta-Hydroxytricarballylate | HMDB | | beta-Hydroxytricarballylic acid | HMDB | | Chemfill | HMDB | | Citraclean | HMDB | | Citretten | HMDB | | Citro | HMDB | | e 330 | HMDB | | Hydrocerol a | HMDB | | Kyselina citronova | HMDB | | Suby g | HMDB | | Uro-trainer | HMDB | | Acid monohydrate, citric | HMDB | | Monohydrate, citric acid | HMDB | | Citric acid, anhydrous | HMDB | | Citric acid monohydrate | HMDB | | Uralyt u | HMDB | | 1,2,3-Propanetricarboxylic acid, 2-hydroxy- (9CI) | biospider | | 2-hydroxypropane-1,2,3-tricarboxylic acid | biospider | | 2-Hydroxypropanetricarboxylic acid | biospider | | E330 | db_source | | FEMA 2306 | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C6H8O7 |
|---|
| IUPAC name | 2-hydroxypropane-1,2,3-tricarboxylic acid |
|---|
| InChI Identifier | InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) |
|---|
| InChI Key | KRKNYBCHXYNGOX-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | OC(=O)CC(O)(CC(O)=O)C(O)=O |
|---|
| Average Molecular Weight | 192.1235 |
|---|
| Monoisotopic Molecular Weight | 192.02700261 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Tricarboxylic acids and derivatives |
|---|
| Direct Parent | Tricarboxylic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tricarboxylic acid or derivatives
- Hydroxy acid
- Alpha-hydroxy acid
- Tertiary alcohol
- Carboxylic acid
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Foods | Fruits and vegetables: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 37.51%; H 4.20%; O 58.29% | DFC |
|---|
| Melting Point | Mp 153° (anhyd.) | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | 592 mg/mL at 25 oC | YALKOWSKY,SH & HE,Y (2003) |
|---|
| Experimental logP | -1.64 | AVDEEF,A (1997) |
|---|
| Experimental pKa | pKa3 6.43 (25°) | DFC |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-002f-9400000000-fb757b614278bb898b54 | 2014-09-20 | View Spectrum | | GC-MS | Citric acid, 4 TMS, GC-MS Spectrum | splash10-0002-0941000000-c310fda0e6a19bf6ae40 | Spectrum | | GC-MS | Citric acid, 4 TMS, GC-MS Spectrum | splash10-0002-0941000000-f1dfda3e9abc7cfb6b2a | Spectrum | | GC-MS | Citric acid, 4 TMS, GC-MS Spectrum | splash10-006t-0952000000-ba3a1a80815f65afd05c | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-0002-0951000000-48857e9baebe16d9fc8d | Spectrum | | GC-MS | Citric acid, 4 TMS, GC-MS Spectrum | splash10-00di-9531000000-b6fd7d038634694f0873 | Spectrum | | GC-MS | Citric acid, 4 TMS, GC-MS Spectrum | splash10-00di-0593000000-b193bbba8c0cefdfe42a | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-0002-0941000000-c310fda0e6a19bf6ae40 | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-0002-0941000000-f1dfda3e9abc7cfb6b2a | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-006t-0952000000-ba3a1a80815f65afd05c | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-0002-0951000000-48857e9baebe16d9fc8d | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-00di-9531000000-b6fd7d038634694f0873 | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-00di-0593000000-b193bbba8c0cefdfe42a | Spectrum | | GC-MS | Citric acid, non-derivatized, GC-MS Spectrum | splash10-0002-0941000000-573230e47a4efb1e36a5 | Spectrum | | Predicted GC-MS | Citric acid, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-002k-6900000000-d1a61a52f6efdec3101a | Spectrum | | Predicted GC-MS | Citric acid, 4 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-02ib-6019300000-6d5ebea10441c6d4149a | Spectrum | | Predicted GC-MS | Citric acid, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_2_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_2_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_2_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_2_4, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_3_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Citric acid, TMS_3_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Negative (Annotated) | splash10-03di-2900000000-956001b034bbc0b7da96 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Negative (Annotated) | splash10-000l-9100000000-55e34e2c1616942fd4f2 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Negative (Annotated) | splash10-000f-9000000000-7b8be3e90a4daf85f04a | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0006-0911200000-af80d22f720facc4813a | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-014i-9000000000-6f4fedbb19821898fb22 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-03di-0900000000-8eff68ab89f7ce2262be | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0fsi-0019300000-b370c4c3dd656c8eb729 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0006-0912100000-05e8ceb6dd97f7b9af98 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-014i-9000000000-e4b67745443c48a63bd6 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-03di-0900000000-92536abec982e0a653a0 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-03di-0190000000-35772df08490f451d828 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-0006-0900000000-35856cc258368d13e1ff | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-03di-3900000000-7170fdcb9749e6d6c2fb | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-01p9-9500000000-9a502981b0a9e1ea35ad | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative | splash10-000i-9100000000-ed0c86b90e1f4966d025 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative | splash10-0a4r-9000000000-b8a975c2d639d8c91afb | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative | splash10-03di-2900000000-30970a4250098e148658 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , negative | splash10-0006-0900000000-a587dddf188152c5d7b0 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , negative | splash10-03di-3900000000-7170fdcb9749e6d6c2fb | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0037-0900000000-06dccacb53e75edc8b8d | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-02cu-5900000000-bfea9d561968b2670b13 | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-002r-7900000000-b1d32e4661447b09a017 | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0005-1900000000-d074598ec2180f8b600c | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0k92-3900000000-9917f196271a495d3d1e | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0pb9-9600000000-513b016c7c951d1e0b12 | 2016-09-12 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 125 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, DMSO-d6, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 22.53 MHz, DMSO-d6, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, D2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, D2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, D2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, D2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 2D NMR | [1H, 1H]-TOCSY. Unexported temporarily by An Chi on Oct 15, 2021 until json or nmrML file is generated. 2D NMR Spectrum (experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 305 |
|---|
| ChEMBL ID | CHEMBL1261 |
|---|
| KEGG Compound ID | C00158 |
|---|
| Pubchem Compound ID | 311 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 30769 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB04272 |
|---|
| HMDB ID | HMDB00094 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HJD14-D:HJD14-D |
|---|
| EAFUS ID | 691 |
|---|
| Dr. Duke ID | CITRIC-ACID |
|---|
| BIGG ID | 34080 |
|---|
| KNApSAcK ID | C00007619 |
|---|
| HET ID | CIT |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | rw1000441 |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Citric_acid |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Allergenic | 50904 | A substance that triggers an immune response, causing allergic reactions. Its biological role is to stimulate the immune system, but it has no therapeutic applications. Key medical uses include diagnosing allergies and developing immunotherapies to desensitize patients to specific allergens, reducing the risk of severe reactions. | DUKE | | Alpha-amylase inhibitor | 50627 | An agent that blocks the activity of alpha-amylase, an enzyme that breaks down carbohydrates. It reduces carbohydrate digestion and absorption, commonly used in managing diabetes, obesity, and weight loss, with potential therapeutic applications in glycemic control and metabolic disorders. | DUKE | | Anti-aphthic | 52217 | An agent that prevents or treats aphthous ulcers, commonly known as canker sores. It reduces inflammation, promotes healing, and alleviates pain, often used in oral care and gastrointestinal treatments to manage recurrent aphthous stomatitis and other mucosal disorders. | DUKE | | Anti-atherosclerotic | 38070 | An agent that prevents or slows the formation of atherosclerosis, a condition characterized by plaque buildup in arteries. It reduces inflammation, improves lipid profiles, and inhibits platelet aggregation, commonly used to manage cardiovascular diseases, such as coronary artery disease, and prevent heart attacks and strokes. | DUKE | | Anti bacterial | 33282 | An agent that inhibits the growth of or destroys bacteria, playing a crucial role in preventing and treating infections. Therapeutically, it is used to combat bacterial infections, with key medical applications including treating pneumonia, tuberculosis, and skin infections, as well as preventing surgical site infections and sepsis. | DUKE | | Anti-calculic | | An agent that prevents or dissolves gallstones and kidney stones, reducing their formation and growth. It plays a biological role in maintaining mineral balance and has therapeutic applications in treating urolithiasis and cholelithiasis, key medical uses include preventing stone recurrence and alleviating associated symptoms. | DUKE | | Anti coagulant | 50249 | An agent that prevents blood clot formation, playing a crucial role in maintaining blood fluidity. Therapeutically, it is used to treat and prevent thrombosis, embolism, and stroke, commonly used in managing conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. | DUKE | | Anti leishmanic | 33281 | An agent that treats Leishmaniasis, a parasitic disease caused by Leishmania parasites. It kills or inhibits the growth of these parasites, reducing symptoms and preventing disease progression. Therapeutically, anti-leishmanics are used to manage cutaneous, visceral, and mucocutaneous Leishmaniasis, often in combination with other treatments. Key medical uses include treating infected individuals, particularly in endemic regions. | DUKE | | Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti-seborrheic | 52217 | An agent that reduces seborrheic dermatitis symptoms, commonly used in managing scalp and skin conditions, such as dandruff, itching, and flaking, by inhibiting fungal growth and inflammation. | DUKE | | Anti septic | 33281 | An agent that prevents or reduces the growth of microorganisms, such as bacteria, fungi, or viruses, to promote wound healing and prevent infection. Therapeutically, anti septics are used to treat minor cuts, scrapes, and burns, and are commonly applied topically to reduce the risk of infection and promote tissue repair. Key medical uses include wound care, surgical site preparation, and skin infection management. | DUKE | | Anti-tubercular | 33282 | An agent that combats tuberculosis, playing a biological role in inhibiting the growth of Mycobacterium tuberculosis. Therapeutically, it is used to treat and prevent tuberculosis, with key medical applications including the treatment of active TB, latent TB, and TB meningitis, as well as preventing the spread of TB in high-risk populations. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Disinfectant | 48219 | An agent that kills or inactivates microorganisms, reducing the spread of infections. Its biological role is to target and eliminate pathogens, including bacteria, viruses, and fungi. Therapeutically, disinfectants are used to prevent and control infections in medical settings, with key applications in wound care, surgical equipment sterilization, and surface sanitation. | DUKE | | Name | 48318 | flavor | DUKE | | Hemostat | | An agent that controls bleeding, playing a biological role in blood coagulation. Therapeutically, it promotes clot formation, and its key medical uses include treating wounds, surgical bleeding, and hemorrhages, helping to stabilize patients and prevent excessive blood loss. | DUKE | | Irritant | | An agent that causes slight inflammation or discomfort, stimulating a biological response. Therapeutically, it can be used to increase blood flow or stimulate healing. Key medical uses include treating wounds, skin conditions, and respiratory issues, such as congestion, by inducing a mild inflammatory response to promote recovery. | DUKE | | Laxative | 50503 | An agent that stimulates bowel movements, relieving constipation by softening stool or increasing intestinal motility. Therapeutically, laxatives are used to treat constipation, prepare the bowel for medical procedures, and manage certain medical conditions, such as irritable bowel syndrome. | DUKE | | Litholytic | | An agent that dissolves calculi, playing a biological role in breaking down kidney stones and other mineral deposits. Its therapeutic applications include treating urolithiasis and nephrolithiasis, with key medical uses in preventing stone recurrence and alleviating associated pain. | DUKE | | Mycobactericide | | An agent that kills bacteria of the genus Mycobacteria, playing a crucial role in treating mycobacterial infections. Therapeutically, it is used to combat tuberculosis, leprosy, and other related diseases, serving as a key medical tool in controlling and eliminating these infections. | DUKE | | Odontolytic | | An agent that promotes resorption of dental tissue, playing a biological role in tooth development and repair. Therapeutically, it is used to dissolve and remove dental hard tissues, with key medical applications in endodontic procedures, such as root canal treatments and tooth decay management. | DUKE | | Refrigerant | 78433 | A substance that absorbs heat, lowering temperatures. No biological role, but used therapeutically in cryotherapy to reduce inflammation and relieve pain. Key medical uses include cooling tissues, preserving organs for transplantation, and treating certain skin conditions. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| ATP-citrate synthase | ACLY | P53396 | | Citrate synthase, mitochondrial | CS | O75390 | | Aconitate hydratase, mitochondrial | ACO2 | Q99798 | | Proto-oncogene tyrosine-protein kinase Src | SRC | P12931 | | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | CTDSP1 | Q9GZU7 | | Carboxypeptidase B | CPB1 | P15086 | | Adenine phosphoribosyltransferase | APRT | P07741 | | Ribonuclease pancreatic | RNASE1 | P07998 | | Macrophage migration inhibitory factor | MIF | P14174 | | Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 | HS3ST3A1 | Q9Y663 | | Angiogenin | ANG | P03950 | | Eosinophil cationic protein precursor | RNASE3 | P12724 |
|
|---|
| Pathways | | Name | SMPDB Link | KEGG Link |
|---|
| Citric Acid Cycle | SMP00057 | map00020 | | Transfer of Acetyl Groups into Mitochondria | SMP00466 | Not Available |
|
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| odorless |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
|
|
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Saxholt, E., et al. 'Danish food composition databank, revision 7.' Department of Nutrition, National Food Institute, Technical University of Denmark (2008).
|
|---|